因带有占所有肺癌病人只1%~2%的RET变异,所以才会对新靶向药BLU-667(或LOXO-292)如此敏感。
因带有占所有肺癌病人只1%~2%的RET变异,所以才会对新靶向药BLU-667(或LOXO-292)如此敏感。
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2025 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy